Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PATRICK W BLAKE

Allopathic & Osteopathic Physicians Dermatology

NPI
1871817312
CMS profile
357803
Location
SAN DIEGO, CA

General Payments · PY2018–2024

$18,278.34

  • Reported across 192 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,112.16

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $881.24 14
Dermavant Sciences, Inc. $548.22 7
E.R. Squibb & Sons, L.L.C. $250.79 2
Janssen Biotech, Inc. $164.06 5
Amgen Inc. $130.17 3
Galderma Laboratories, L.P. $58.91 1
REVANCE THERAPEUTICS, INC. $30.90 1
Arcutis Biotherapeutics, Inc. $24.26 1
UCB, Inc. $23.61 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $826.19 11
PY2019 $915.74 16
PY2020 $321.52 7
PY2021 $1,133.64 28
PY2022 $1,484.45 25
PY2023 $11,484.64 70
PY2024 $2,112.16 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $158.13 02/02/2024 Food and Beverage Undisputed 01/23/2026 1103334152 CMS
ABBVIE INC. $130.00 02/03/2024 Food and Beverage Undisputed 01/23/2026 1103334154 CMS
ABBVIE INC. $133.89 03/10/2024 Food and Beverage Undisputed 01/23/2026 1103334156 CMS
ABBVIE INC. $8.45 04/15/2024 Education Undisputed 01/23/2026 1104194426 CMS
ABBVIE INC. $8.45 04/15/2024 Education Undisputed 01/23/2026 1104194428 CMS
ABBVIE INC. $8.45 04/15/2024 Education Undisputed 01/23/2026 1104194430 CMS
ABBVIE INC. $8.45 04/15/2024 Education Undisputed 01/23/2026 1104194432 CMS
ABBVIE INC. $8.45 06/03/2024 Education Undisputed 01/23/2026 1104194434 CMS
ABBVIE INC. $8.45 06/10/2024 Education Undisputed 01/23/2026 1104194436 CMS
ABBVIE INC. $4.96 06/17/2024 Food and Beverage Undisputed 01/23/2026 1103334158 CMS
ABBVIE INC. $22.20 06/26/2024 Food and Beverage Undisputed 01/23/2026 1103334160 CMS
ABBVIE INC. $136.36 06/28/2024 Food and Beverage Undisputed 01/23/2026 1103334162 CMS
ABBVIE INC. $149.00 09/26/2024 Food and Beverage Undisputed 01/23/2026 1103334164 CMS
ABBVIE INC. $96.00 12/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1103141643 CMS
Amgen Inc. $17.43 04/10/2024 Food and Beverage Undisputed 01/23/2026 1117508824 CMS
Amgen Inc. $94.71 04/18/2024 Food and Beverage Undisputed 01/23/2026 1117508826 CMS
Amgen Inc. $18.03 12/11/2024 Food and Beverage Undisputed 01/23/2026 1117508828 CMS
Arcutis Biotherapeutics, Inc. $24.26 01/11/2024 Food and Beverage Undisputed 01/23/2026 1121067845 CMS
Dermavant Sciences, Inc. $25.08 02/29/2024 Food and Beverage Undisputed 01/23/2026 1127852204 CMS
Dermavant Sciences, Inc. $81.25 04/14/2024 Food and Beverage Undisputed 01/23/2026 1127852206 CMS
Dermavant Sciences, Inc. $25.78 07/14/2024 Food and Beverage Undisputed 01/23/2026 1127852208 CMS
Dermavant Sciences, Inc. $134.33 08/06/2024 Food and Beverage Undisputed 01/23/2026 1127852210 CMS
Dermavant Sciences, Inc. $31.78 10/24/2024 Food and Beverage Undisputed 01/23/2026 1127852212 CMS
Dermavant Sciences, Inc. $180.00 10/26/2024 Food and Beverage Undisputed 01/23/2026 1127852214 CMS
Dermavant Sciences, Inc. $70.00 12/22/2024 Food and Beverage Undisputed 01/23/2026 1127852216 CMS
E.R. Squibb & Sons, L.L.C. $112.79 02/21/2024 Food and Beverage Undisputed 01/23/2026 1101852418 CMS
E.R. Squibb & Sons, L.L.C. $138.00 07/19/2024 Food and Beverage Undisputed 01/23/2026 1101852455 CMS
Galderma Laboratories, L.P. $58.91 06/05/2024 Food and Beverage Undisputed 01/23/2026 1145286819 CMS
Janssen Biotech, Inc. $11.34 01/19/2024 Food and Beverage Undisputed 01/23/2026 1078325702 CMS
Janssen Biotech, Inc. $106.01 02/22/2024 Food and Beverage Undisputed 01/23/2026 1078324786 CMS
Janssen Biotech, Inc. $6.52 07/18/2024 Food and Beverage Undisputed 01/23/2026 1078324863 CMS
Janssen Biotech, Inc. $21.46 08/28/2024 Food and Beverage Undisputed 01/23/2026 1078327336 CMS
Janssen Biotech, Inc. $18.73 10/30/2024 Food and Beverage Undisputed 01/23/2026 1078326057 CMS
REVANCE THERAPEUTICS, INC. $30.90 10/25/2024 Food and Beverage Undisputed 01/23/2026 1147912950 CMS
UCB, Inc. $23.61 09/11/2024 Food and Beverage Undisputed 01/23/2026 1143270126 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.